GB9407386D0
(en)
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
NZ318282A
(en)
|
1995-09-07 |
2000-01-28 |
Smithkline Beecham Corp |
Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
|
TWI225402B
(en)
|
1996-03-13 |
2004-12-21 |
Biochemie Gmbh |
Auxiliary-free agglomerates
|
AT407214B
(de)
*
|
1996-03-13 |
2001-01-25 |
Biochemie Gmbh |
Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
|
AT407701B
(de)
*
|
1996-08-12 |
2001-05-25 |
Biochemie Gmbh |
Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
|
US20030124187A1
(en)
*
|
1997-02-14 |
2003-07-03 |
Smithkline Beecham Laboratoires Pharmaceutiques, |
Pharmaceutical formulations comprising amoxycillin and clavulanate
|
US7179486B1
(en)
*
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
KR100502478B1
(ko)
*
|
1997-06-13 |
2005-12-02 |
동아제약주식회사 |
클라불란산과베타락탐계항생물질을포함하는세균감염증치료제용약학적조성물
|
AUPP437698A0
(en)
|
1998-06-30 |
1998-07-23 |
Baumgart, Karl |
Methods for treatment of coronary, carotid and other vascular disease
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6294199B1
(en)
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
GB2365337A
(en)
*
|
1999-04-13 |
2002-02-20 |
Beecham Pharma |
Amoxycillin and potassium clavulanate high dosage regimen
|
AR031068A1
(es)
*
|
1999-04-13 |
2003-09-10 |
Beecham Pharm Pte Ltd |
Una formulacion farmaceutica de liberacion modificada que comprende amoxicilina y clavulanato de potasio en una relacion de 2:1 a 20:1, un comprimido en capas, el uso de la amoxicilina y el clavulanato de potasio para la fabricacion de un medicamento, un equipo y granulos compactos
|
US6632453B2
(en)
|
2000-02-24 |
2003-10-14 |
Advancis Pharmaceutical Corp. |
Ciprofoxacin-metronidazole antibiotic composition
|
US7025989B2
(en)
|
2000-02-24 |
2006-04-11 |
Advancis Pharmaceutical Corp. |
Multiple-delayed released antibiotic product, use and formulation thereof
|
US6730320B2
(en)
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
US6627222B2
(en)
|
2000-02-24 |
2003-09-30 |
Advancis Pharmaceutical Corp. |
Amoxicillin-dicloxacillin antibiotic composition
|
US6610328B2
(en)
|
2000-02-24 |
2003-08-26 |
Advancis Pharmaceutical Corp. |
Amoxicillin-clarithromycin antibiotic composition
|
US6638532B2
(en)
|
2000-02-24 |
2003-10-28 |
Advancis Pharmaceutical Corp. |
Tetracycline—doxycycline antibiotic composition
|
US6667042B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Fluroquinilone antibiotic product, use and formulation thereof
|
US6663890B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Metronidazole antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
AU3986901A
(en)
*
|
2000-02-24 |
2001-09-03 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US6623758B2
(en)
|
2000-02-24 |
2003-09-23 |
Advancis Pharmaceutical Corp. |
Cephalosporin-metronidazole antibiotic composition
|
US6669948B2
(en)
|
2000-02-24 |
2003-12-30 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
CA2400818C
(en)
|
2000-02-24 |
2009-01-06 |
Advancis Pharmaceutical Corporation |
Antibiotic and antifungal compositions
|
US6663891B2
(en)
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Erythromyacin antibiotic product, use and formulation thereof
|
US6667057B2
(en)
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Levofloxacin antibiotic product, use and formulation thereof
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
AU2001254798A1
(en)
|
2000-04-07 |
2001-10-23 |
Sofitech N.V. |
Scale removal
|
US6761895B2
(en)
*
|
2000-04-17 |
2004-07-13 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US6375982B1
(en)
*
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
AU2001279284A1
(en)
*
|
2000-07-05 |
2002-01-14 |
Capricorn Pharma, Inc |
Rapid-melt semi-solid compositions, methods of making same and methods of using same
|
EP1330236A2
(de)
|
2000-10-12 |
2003-07-30 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillinhaltige arzneizusammensetzungen
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US7157095B2
(en)
*
|
2000-10-13 |
2007-01-02 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release antifungal product, use and formulation thereof
|
US7105174B2
(en)
*
|
2000-10-13 |
2006-09-12 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-neoplastic product, use and formulation thereof
|
US7074417B2
(en)
*
|
2000-10-13 |
2006-07-11 |
Advancis Pharmaceutical Corporation |
Multiple-delayed release anti-viral product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
GB0031267D0
(en)
*
|
2000-12-21 |
2001-01-31 |
Smithkline Beecham Plc |
Novel compositions
|
US20020197314A1
(en)
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
CA2440588C
(en)
*
|
2001-03-13 |
2010-02-09 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
DE10391497D2
(de)
*
|
2002-04-12 |
2005-05-19 |
Edscha Cabrio Dachsys Gmbh |
Verdeck für ein Cabriolet-Fahrzeug
|
US20040114368A1
(en)
*
|
2002-12-13 |
2004-06-17 |
Shyu Shing Jy |
Light device having rotatable or movable view
|
US8313775B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
US8313776B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
WO2005009364A2
(en)
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
EP1653925A1
(de)
|
2003-08-11 |
2006-05-10 |
Advancis Pharmaceutical Corporation |
Robustes pellet
|
CA2535398C
(en)
|
2003-08-12 |
2013-11-12 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
JP2007513869A
(ja)
|
2003-09-15 |
2007-05-31 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
WO2005027878A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Delayed released dosage forms
|
US20050118267A1
(en)
*
|
2003-09-19 |
2005-06-02 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
US20050142187A1
(en)
*
|
2003-12-24 |
2005-06-30 |
Treacy Donald J.Jr. |
Enhanced absorption of modified release dosage forms
|
WO2005065685A1
(en)
*
|
2004-01-06 |
2005-07-21 |
Panacea Biotec Ltd. |
Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
|
WO2005099672A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
FR2872044B1
(fr)
*
|
2004-06-28 |
2007-06-29 |
Flamel Technologies Sa |
Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
|
US8715727B2
(en)
|
2004-07-02 |
2014-05-06 |
Shionogi Inc. |
Tablet for pulsed delivery
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
CN101371005B
(zh)
|
2006-01-27 |
2013-07-17 |
普拉德研究及开发股份有限公司 |
用于地层的水力压裂的方法
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US9120963B2
(en)
*
|
2006-11-08 |
2015-09-01 |
Schlumberger Technology Corporation |
Delayed water-swelling materials and methods of use
|
JP5524624B2
(ja)
*
|
2007-11-16 |
2014-06-18 |
旭化成ケミカルズ株式会社 |
水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
|
JP5101324B2
(ja)
*
|
2008-02-07 |
2012-12-19 |
日立建機株式会社 |
建設機械のNOx低減装置の配設構造
|
US8839865B2
(en)
*
|
2008-02-27 |
2014-09-23 |
Schlumberger Technology Corporation |
Slip-layer fluid placement
|
US9097077B2
(en)
*
|
2009-10-30 |
2015-08-04 |
Schlumberger Technology Corporation |
Downhole chemical delivery system and method
|
US8448706B2
(en)
|
2010-08-25 |
2013-05-28 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
US8459353B2
(en)
|
2010-08-25 |
2013-06-11 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
US8714248B2
(en)
|
2010-08-25 |
2014-05-06 |
Schlumberger Technology Corporation |
Method of gravel packing
|
US9234415B2
(en)
|
2010-08-25 |
2016-01-12 |
Schlumberger Technology Corporation |
Delivery of particulate material below ground
|
EP3007568A4
(de)
|
2013-06-13 |
2016-11-09 |
Griffith Laboratories |
Verwendung resistenter stärken in beschichtungszusammensetzungen
|
US11278506B2
(en)
|
2015-10-09 |
2022-03-22 |
Rb Health (Us) Llc |
Pharmaceutical formulation
|
US10624899B2
(en)
|
2016-07-14 |
2020-04-21 |
Achaogen, Inc. |
Combination products for the treatment of bacterial infections and methods of producing or dosing of same
|
JP2024506595A
(ja)
|
2021-02-23 |
2024-02-14 |
大塚製薬株式会社 |
センタナファジン製剤ならびにその製造および使用方法
|